|
|
INTERCEPT Plasma: Abstracts
2008 ABSTRACTS
Jump to conference:
June - ISBT
XXXth International Congress of the International Society of Blood Transfusion (ISBT)
June 7–12, 2008 | Macao, China
- M Steiert, E Castro, P Grellier, J Benach, WC Van Voorhis, RT Eastman, K Dupuis, L Sawyer, L Lin. Photochemical Inactivation with Amotosalen and UVA Light of Protozoan Parasites in Platelet and Plasma Components Using INTERCEPT Blood System.
Vox Sang 2008;95(Suppl 1):291
- K Dupuis and L Sawyer. Inactivation of Influenza Virus Type A H5N1 in Platelets and Plasma by Treatment with the INTERCEPT Blood System.
Vox Sang 2008;95(Suppl 1):301
- F Knutson, K Lejskog, M Ståhle, O Korsgren. The INTERCEPT Technology as Novel Approach for the Generation of Pathogen Inactivated Serum for the Culturing of Pancreatic Islets: Opportunities for Improvements.
Vox Sang 2008;95(Suppl 1):279
- L Pinkoski, T Peterson, J Bayat, L Corash. Coagulation Factor Activity In INTERCEPT Plasma after Storage for 24 Months at -25° C.
Vox Sang 2008;95(Suppl 1):288
- A Rapaille, N de Valensart, E Goossenaerts, J Irsch, L Lin, V Deneys. INTERCEPT Treatment for Pathogen Inactivation of Thawed Plasma: Coagulation Factors and Function are Preserved.
Vox Sang 2008;95(Suppl 1):292
- N de Valensart, A Rapaille, E Goossenaerts, J Irsch, L Lin, V Deneys. Analysis of the Impact of INTERCEPT Treatment on Fresh Plasma: Preservation of Coagulation Factors and Inhibitors Functional Activity.
Vox Sang 2008;95(Suppl 1):293
- JC Osselaer, L Defoin, M Goffaux, M Vandendaele, L Lin, E Goossenaerts, P Carmichael. Routine Production of Three Plasma Products from One INTERCEPT Blood System Treatment.
Vox Sang 2008;95(Suppl 1):294
- JP Cazenave, JC Osselaer, C Waller, M Jacquet, L Lin, L Corash, and D Sundin. Results from an Ongoing Hemovigilance Program Using an Electronic Data Capture System to Characterize the Safety Profile of Plasma Transfusions Prepared with the INTERCEPT Blood System.
Vox Sang 2008;95(Suppl 1):296
- JP Cazenave, P Netzer, C Ravanat, A Boucher, H Isola, D Kientz, C Gachet, ML Wiesel. Thrombin Generation Capacity of Therapeutic Apheresis Plasma is Maintained Following Pathogen Inactivation with Photochemical Treatment (INTERCEPT Blood System).
Vox Sang 2008;95(Suppl 1):306
- H Isola, D Kientz, F Bigey, C Waller, M Laforet, ML Wiesel, JP Cazenave. Implementation of Pathogen Inactivated Therapeutic Apheresis Plasma Following Photochemical Treatment with INTERCEPT by EFS-Alsace, a French Regional Blood Center.
Vox Sang 2008;95(Suppl 1):306-307
- M Naegelen, H Isola, P Morel, JP Cazenave. Impact on Organization of Production of Inactivated Therapeutic Plasma with Two Photochemical Treatments, Methylene Blue or Amotosalen, in Two French Regional Blood Centers.
Vox Sang 2008;95(Suppl 1):309
2007 ABSTRACTS
Jump to conference:
December - ASH
October - AABB
June - ISBT
American Society of Hematology (ASH) • Dec. 8 –11, 2007, Atlanta, Georgia
Return to top menu
- JP Cazenave, P Netzer, S Schuhler, C Ravanat, H Isola, D Kientz, C Gachet, ML Wiesel. Retention of Thrombin Generation Capacity of Therapeutic Apheresis Plasma Prepared with Amotosalen and UVA Light (INTERCEPT) Pathogen Inactivation.
Blood 2007;110(11):75B
American Association of Blood Banks Annual Meeting (AABB) • Oct. 20 –23, 2007, Anaheim, California, USA top
- L Pinkoski, L Corash. Complement Factors H and I Are Conserved in Plasma After Pathogen Inactivation With Amotosalen and UVA Light.
Transfusion 2007;47 (S3):72A
International Society for Blood Transfusion (ISBT) • June 24-27, 2007, Madrid, Spain top
- JC Osselaer, C Debry, M Goffaux, E Dubuc, B Chatelain, MC Vandendaele. Coagulation Function in Fresh Frozen Plasma Prepared with Two Photochemical Treatment Methods.
[Poster PDF]
- E Castro, JL Bueno, M Díaz-Ricart, M Palomo, G Escolar. The Effect of Photochemical Treatment (PCT) with Amotosalen and UVA Light on Coagulation Function of Concurrent Plasma from Platelet Apheresis.
[Poster PDF]
- J Cid, O Magallon, M Claparols, A Pinacho, P Ortiz, L Puig, RP Pla. Levels Of Coagulation Factors in Fresh Frozen Plasma Obtained from Whole Blood Donations and Prepared with Two Photochemical Treatment Methods.

2006 ABSTRACTS
Jump to conference:
December - ASH
October - AABB
September - ISBT
March - ICEID
American Society of Hematology (ASH) • December 9 – 12, 2006, Orlando, Florida, USA top
- Jean-Pierre Cazenave, Hervé Isola, Marie-Louise Wiesel, Daniel Kientz, Michel Laforêt, Marc Slaedts, Linda Pinkoski, Yasmin Singh and Laurence Corash. Coagulation Factors In Therapeutic Apheresis Plasma Held For 18 Hours At Ambient Temperature Prior To Pathogen Inactivation (INTERCEPT™).
[Poster PDF]
- Jean-Pierre Cazenave, Hervé Isola, Marie-Louise Wiesel, Daniel Kientz, Michel Laforêt, Linda Pinkoski, Yasmin Singh and Laurence Corash. Coagulation Factor Activity In Therapeutic Plasma Prepared From Whole Blood With Pathogen Inactivation (INTERCEPT™) Treatment.
- Markus M. Mueller, Hans-Ulrich Pfeiffer, Margaret Rheinschmidt, Bernd Poetzsch, Johannes Oldenburg, Laurence Corash, Erhard Seifried and Reinhard Henschler. Effects of Pathogen Inactivation Using Amotosalen on Coagulation Parameters in Apheresis and Whole Blood Derived Fresh Frozen Plasma in a Large Blood Bank Setting.
American Association of Blood Banks (AABB) • Oct. 21-24, 2006,
Miami Beach, FL top
- L. Pinkoski, T. Peterson, Y. Singh, L. Corash. Coagulation Factor Activity in Photochemically Treated Plasma Prepared From Previously Frozen Plasma.
[Poster PDF]
- L. Pinkoski, T. Peterson, Y. Singh, L. Corash. Coagulation Factor Activity in Photochemically Treated Plasma After Storage at 18ºC or –25ºC.
[Poster PDF]
- Sawyer L, Hsu J, Bernard K, Sampson-Johannes A, Dupuis K, Pinna D, Lane R, Grellier P, Van Voorhis W, Benach J, Lin L. Inactivation of Emergent Blood-borne Pathogens in Plasma and Platelets.
[Poster PDF]
International Society for Blood Transfusion (ISBT) • Sept. 2-7 2006, Cape Town, South Africa top
- JP Cazenave, H Isola, M-L Wiesel, D Kientz, M Laforêt, V Mayaudon, L Pinkoski, Y Singh, L Corash. Stability of Coagulation Factors in Plasma Prepared with Photochemical Treatment (INTERCEPT) Stored for One Year.
[Poster PDF]
- JC Osselaer, C Debry, M Goffaux, E Dubuc, B Chatelain, M Rheinschmidt, L Lin. Coagulation Function in Fresh Frozen Plasma Prepared with Two Photochemical Treatment Methods
[Poster PDF]
- L Corash, N Bass, L Petz, R Steadman, M Streiff, J McCullough, P Mintz. Fresh Frozen Plasma for Management of Hemostasis During Minor and Major Surgical Procedures Associated With Coagulopathy.
[Poster PDF]
- L Pinkoski, T Peterson, J Bayat, H Evans, Y Singh, L Corash. Coagulation Factor Activity in 180 mL and 325 mL Units of Photochemically Treated Plasma (INTERCEPT Plasma) After Storage for 12 Months at -18ºC.
[Poster PDF]
- L Sawyer, K. Dupuis, A. Sampson-Johannes, T. Dubensky, D.L. Vanlandingham, K. Tsetsarkin S. Higgs. Inactivation of Chikungunya Virus in Plasma and Platelets Using Helinx Technology, as Utilized in the INTERCEPT Blood System
[Poster PDF]
International Conference on Emerging Infectious Diseases (ICEID) • March 19-22, 2006, Atlanta, Georgia top
- L Sawyer, J Benach, K Bernard, K Dupuis, P Grellier, JC Hsu, R Lane, L Lin, A Sampson-Johannes, W van Voorhis, E Vicenzi. Inactivation of Emergent Blood-borne Pathogens in Plasma and Platelets Using the INTERCEPT Blood System.
[Poster PDF]
|
 |